Enter assignee name

EPO Patents = 2

Trademarks = 2

Forward Citations = 87

Loading Chart...

6 inventors (with patents filed for the assignee):

Alan R Meyer (9 out of 13 patents)

William H Pitlick (3 out of 8 patents)

Konstantinos Charizanis (3 out of 8 patents)

4. Mina Sooch (3 out of 8 patents)

5. Bernhard Hoffmann (3 out of 7 patents)

6. Daniela Carmen Oniciu (2 out of 16 patents)

11 patents: Sort by Forward Citations

1. 12016841 - Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders (2024-06-25),

2. 11976044 - Highly pure phentolamine mesylate (2024-05-07),

3. 11844858 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof (2023-12-19),

4. 11717510 - Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance (2023-08-08),

5. 11566005 - Highly pure phentolamine mesylate and methods for making same (2023-01-31),

6. 11400077 - Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders (2022-08-02),

7. 11090261 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof (2021-08-17),

8. 11000509 - Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance (2021-05-11),

9. 10993932 - Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders (2021-05-04),

10. 10772829 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof (2020-09-15),

11. 10278918 - Aqueous ophthalmic solutions of phentolamine and medical uses thereof (2019-05-07),

Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of various eye disorders. The company's pipeline includes multiple product candidates targeting retinal and front of the eye diseases. Ocuphire Pharma is dedicated to improving the lives of patients with innovative and effective ophthalmic solutions.

This text is generated by artificial intelligence and may not be accurate.